Clinical Trial Update: Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study evaluating NVC-422 for asymptomatic bacteriuria in catheterized patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asymptomatic Bacteriuria

Drugs mentioned

• NVC-422

Snippet

Sponsor: NovaBay Pharmaceuticals, Inc. | Conditions: Asymptomatic Bacteriuria | Phase 2 | Status: COMPLETED